Global /United States /Healthcare /Medical Devices /MLAB
chevron_leftBack
Mesa Laboratories, Inc. logo

Mesa Laboratories, Inc.

MLAB
NASDAQ: MLAB Delayed
95.70USD -3.8%
As of 14 June 2026, Mesa Laboratories, Inc. has a market cap of $528.7M USD, ranking #14754 globally and #2590 in the United States. It ranks #1311 in the Healthcare sector, and #267 in the Medical Devices industry.
Global Rank
14754
Country Rank
2590
Sector Rank
1311
Industry Rank
267
Key Stats
Market Cap
$528.7MUSD
Enterprise Value
$691.97MUSD
Revenue (TTM)
$247.54MUSD
EBITDA (TTM)
$42.25MUSD
Net Income (TTM)
$3.73MUSD
EBITDA Margin
17%
Profit Margin
1.5%
PE Ratio
140.7
Forward PE
69.0
PS Ratio
2.2
PB Ratio
2.9
EV/EBITDA
16.4
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
Siddhartha Kadia open_in_new
Employees
730
Founded
1982
Website
mesalabs.com open_in_new
1d 1w 1m 3m 6m 1y
-3.8% -4.6% 18% 23% 24% -17%

News

Loading...

MLAB Analyst Forecasts

Loading...

Markets

Exchange Ticker Price
NASDAQ
MIC: XNAS
PRIMARY
MLAB
Mesa Laboratories Inc
ISIN: US59064R1095
Shares Out.:
5.525M1 Shares Float: 5.347M2
TV:
SA:
YF:
GF:
NQ:
BA:
MS:
95.70 USD
Frankfurt Stock Exchange
MIC: XFRA
MLI
Mesa Laboratories Inc
ISIN: US59064R1095
Shares Out.:
5.525M1 Shares Float: 5.347M2
TV:
SA:
YF:
GF:
BA:
MLI
MS:
84.00 EUR
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Mesa Laboratories, Inc.

Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides testing and laboratory services to the dental and pharmaceutical industries. Its Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for inherited genetic disease testing, pharmacogenetics, oncology testing, infectious disease testing, doping and toxicology testing, and other differentiated applications for use in research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; PurePep Chorus and Symphony instruments for peptide synthesis; and PurePep EasyClean products for purifying peptides. Its Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as environmental and process monitoring, dialysis, gas flow, air quality, and torque testing in medical device and pharmaceutical manufacturing, laboratory, and hospital environments. This segment’s products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems under DialyGuard, ViewPoint, DataTrace, DryCal, and BGI brands. Mesa Laboratories, Inc. was incorporated in 1982 and is headquartered in Lakewood, Colorado.

Similar Companies

Industry: Medical Devices (United States)
Name
Market Cap diff.
PE
$173.27B
33K%
25.8
$160.73B
30K%
56.7
$159.07B
30K%
25.6
DHR
$126.55B
24K%
34.7
SYK
$120.69B
23K%
38.3
$84.93B
16K%
24.5
Industry: Medical Devices (Global)
Name
Market Cap diff.
PE
MDT
$101.9B
19K%
22.2
$97.46B
84.32B EUR
18K%
36.7
7741
$61.41B
9.83T JPY
12K%
40.0
$45.47B
39.34B EUR
9K%
18.7
ALC
$36.38B
28.99B CHF
7K%
37.9
$30.06B
203.66B CNY
6K%
26.0
chevron_leftBack